RE:RE:RE:RE:RE:RE:For a second day in a row... Lol, 48 days ago there was insufficient information for anybody to discuss the scope of the disease, digitel. There wasn't even a name for it until February 11. I wasn’t prepared to go all Chicken Little over it like you did. Still not willing to do that. xB3’s capabilities will not be affected by COVID-19. The need for brain tumour and other neurodisease treatments is not going away. There is business to be done by Bioasis. Lots of it.
I talked about the Denali, Goldman Sachs raise, but they were the ones that did it, not I. They're the experts, not I. Go talk to them, digitel. Denali announced the pricing of that financing at $23 on January 29, two days after it hit a high of $30.41. Denali hit its low for the year of $12.39 on Thursday. It's come back to $16 but that's a ways from $30 two months ago.
On the other hand, Bioasis has pretty much traded within its recent range - from 20¢ to the mid to high twenties. Its low for the year was back in October. (17.5¢) It's nothing to write home about but it's probably a fair price given Bioasis' past failures and lack of APPARENT progress. I do hope and think that we can break out of that soon.
digitel, there's nothing smart about copy/pasting. There's nothing enlightening in stuff you post if we've already read it elsewhere. There's nothing enlightening in the numbingly repetitive posts from you, BMT and the one who's been there but came back MT. None of you 3 and others like you can discuss Bioasis as a business proposition. None of you can discuss the place that xB3 can play in neurodisease treatment. All you can do is recount the past, as if the rest of us don't remember. It's a hellish past, digitel, and likely that we agree about the reasons why.
18 and 4 SHOULD HAVE HAPPENED. Talk to the people who ran the show about why it didn't happen. They had xB3 and they blew it! Boy, I did my part. I was paid less than a tenth of what Catherine London and Sterns were paid and yet I wrote more stuff about Bioasis and xB3 than they. I talked and otherwise communicated with more people than they ever dreamt of doing. I described the science, reviewed competitors' claims, shut down people like you who pumped things like like ZW49, a drug intended for patients who do not respond well to Herceptin. I have hit over 5000 SH reads in some months, with far fewer posts than you, digitel.
And let's get something straight. I am smart, smart enough, at least. More to the point, I study stuff, a lot of stuff. I was born that way and I've spent my life dealing with people who resent it. Get used to me fighting back. If you bash it, I will argue with you. If you overpump it, I will argue with you. If you are simply wrong about stuff (like ZW49) I will correct you or argue with you, whatever it takes. Truth is what is important.
Despite all the damage and pain that you, digitel, and your mindless sycophants have inflicted on Bioasis and its shareholders, xB3 is still gold. No virus, no SH poster, no CEO, no pandemic, no recession, not I, nothing can change the inherent capability and value of xB3. Somebody, I hope it’s DrDR, will get that in the bank for us.
Ok. As you were...
jdstox